Long-term results of extensive aortoiliac occlusive disease (EAIOD) treated by endovascular therapy and risk factors for loss of primary patency
闭塞的疾病(EAIOD ) 为主要明显的损失由 endovascular 治疗和风险因素对待的广泛的 aortoiliac 的长期的结果作者机构：Institute of Vascular SurgeryDepartment of Vascular SurgeryZhongshan HospitalFudan UniversityCenter for Vascular Surgery and Wound CareJinshan HospitalFudan UniversityShanghai 201508China
出 版 物：《Chinese Medical Journal》 (中华医学杂志（英文版）)
年 卷 期：2021年第134卷第8期
页 面：913-919页
核心收录：
学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学]
基 金：the National Nature Science Funds(No.81970407) the Training Program for Outstanding Academic Leaders of the Shanghai Health and Family Planning System[Hundred Talent Program,No.2018BR40] the Project of Outstanding Academic Leaders of Shanghai Science and Technology Commission[No.19XD1401200] the Training Project for“Future Star”Doctor of Fudan University(2019)
主 题：Critical limb ischemia Endovascular therapy Extensive aortoiliac occlusive disease Mortality Primary patency Risk factors
摘 要：Background::Although endovascular therapy has been widely used for focal aortoiliac occlusive disease(AIOD),its performance for extensive AIOD(EAIOD)is not fully *** aimed to demonstrate the long-term results of EAIOD treated by endovascular therapy and to identify the potential risk factors for the loss of primary ***::Between January 2008 and June 2018,patients with a clinical diagnosis of the 2007 TransAtlantic Inter-Society Consensus II(TASC II)C and D AIOD lesions who underwent endovascular treatment in our institution were ***,diagnosis,procedure characteristics,and follow-up information were *** analysis was used to identify the correlation between the variables and the primary patency.A multivariate logistic regression model was used to identify the independent risk factors associated with primary ***-and 10-year primary and secondary patency,as well as survival rates,were calculated by Kaplan-Meier ***::A total of 148 patients underwent endovascular treatment in our *** these,39.2%were classified as having TASC II C lesions and 60.8%as having TASC II D *** technical success rate was 88.5%.The mean follow-up time was 79.2±29.2 *** and secondary patency was 82.1%and 89.4%at 5 years,and 74.8%and 83.1%at 10 years,*** 5-year survival rate was 84.2%.Compared with patients without loss of primary patency,patients with this condition showed significant differences in age,TASC II classification,infrainguinal lesions,critical limb ischemia(CLI),and *** logistic regression analysis showed age61 years(adjusted odds ratio[aOR]:6.47;95%CI:1.47-28.36;P=0.01),CLI(aOR:7.81;95%CI:1.92-31.89;P=0.04),and smoking(aOR:10.15;95%CI:2.79-36.90;P0.01)were independent risk factors for the loss of primary ***::Endovascular therapy was an effective treatment for EAIOD with encouraging patency and survival ***61 years,CLI,and smoking
维普期刊数据库
同方期刊数据库